Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo

Citation
N. Tamai et al., Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo, J BIOMED MR, 59(1), 2002, pp. 110-117
Citations number
23
Categorie Soggetti
Multidisciplinary
Journal title
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
ISSN journal
00219304 → ACNP
Volume
59
Issue
1
Year of publication
2002
Pages
110 - 117
Database
ISI
SICI code
0021-9304(200201)59:1<110:NHCWAI>2.0.ZU;2-#
Abstract
Calcium hydroxyapatite ceramics (CHA) are nontoxic materials, provoke littl e reaction from tissues, and by virtue of these properties represent a good starting point for creating bone substitutes. Although several porous CHAs have been used clinically, there have been few reports that CHA is fully r eplaced by newly formed bone, which may be due to its structure and the lim ited connectivity between pores. We recently developed a fully interconnect ed porous CHA (IP-CHA) by adopting a "foam-gel" technique. Structural analy sis by scanning electron microscopy revealed that IP-CHA had spherical pore s of uniform size that were interconnected by window-like holes. The surfac e of the wall structure was smooth, and hydroxyapatite particles were bound tightly to one another. Most of the interpore connections of IP-CHA ranged from 10 to 80 mum in diameter (average, 40 mum). When the cylindrical IP-C HA (diameter, 6 mm; height, 15 mm) was implanted into a rabbit femoral cond yle, bone, and bone marrow with abundant vessels formed deep in the pores t hrough the interpore connections. Within a period of 6 weeks, new bone had formed and penetrated to a distance of 3 mm from the surface of the IP-CHA implant. Furthermore, a compression test at 9 weeks revealed that the impla nted IP-CHA steadily increased in strength to more than double the value of the initial test. These results indicate that the IP-CHA may have clinical utility as a superior bone substitute. (C) 2001 John Wiley & Sons, Inc.